Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Geron Management Discusses Q3 2012 Results - Earnings Call Transcript
Seeking Alpha
Wednesday, October 31, 2012 - 11:42am
tags:
earnings, Geron
FDA Releases its Briefing Concerning Rescheduling of Hydrocodone Combination Products in Advance of Advisory Committee Meeting
FDA Law Blog
Wednesday, October 31, 2012 - 11:41am
tags:
FDA, hydrocodone
3 Biotechs Investors Should Be Scared Of
Motley Fool
Wednesday, October 31, 2012 - 11:40am
tags:
Amarin, Alexion, Spectrum Pharmaceuticals
Biogen Idec's BG-12 PDUFA Delay is a Buying Opportunity
Yahoo/Reuters
Wednesday, October 31, 2012 - 11:38am
tags:
Biogen Idec, BG-12
Biogen Hemophilia A Therapy Helps in Fewer Injections
Bloomberg
Wednesday, October 31, 2012 - 11:37am
tags:
Biogen Idec, hemophilia, rFVIIIFc
Teva: Copaxone And Management Uncertainty May Be Hiding One Of The Last Bargains Around
Seeking Alpha
Wednesday, October 31, 2012 - 11:16am
tags:
Teva, Copaxone
BMJ editor flogs Roche for Tamiflu data secrecy
Fierce Pharma
Wednesday, October 31, 2012 - 11:15am
tags:
Roche, clinical trials, Tamiflu, British Medical Journal
Novo hikes forecast on 62% jump in Victoza sales
Fierce Pharma
Wednesday, October 31, 2012 - 11:14am
tags:
Novo Nordisk, guidance
Can Merck Wake The Sleeping Pill Market? It Depends On Ambien's Side Effects
Forbes
Wednesday, October 31, 2012 - 11:03am
tags:
Merck, insomnia, Ambien
Glaxo Profit Misses Estimates as Pricing Hurts Europe Sales
Bloomberg
Wednesday, October 31, 2012 - 10:59am
tags:
earnings, GSK
Dynavax Advances Agonist For Asthma Into The Clinic
Seeking Alpha
Wednesday, October 31, 2012 - 10:49am
tags:
Dynavax, asthma, TLR-9, AZD-1419
UCB Reports 9M Sales Results
Yahoo/Zacks.com
Wednesday, October 31, 2012 - 10:09am
tags:
UCB Pharmaceuticals, earnings
Failed AstraZeneca Drugs Seen Holding Key to Next Viagra
Bloomberg
Wednesday, October 31, 2012 - 10:05am
tags:
Viagra, AstraZeneca, UK, Medical Research Council
Allergan Posts Flat Q3 Profit, Lifts Low End Of Earnings Outlook
NASDAQ.com
Tuesday, October 30, 2012 - 11:49am
tags:
earnings, Allergan
Revenues Fall at ViroPharma
Yahoo/Zacks.com
Tuesday, October 30, 2012 - 11:47am
tags:
earnings, ViroPharma
Exact Sciences Reports Third-Quarter 2012 Financial Results
Yahoo
Tuesday, October 30, 2012 - 11:46am
tags:
earnings, EXACT Sciences
Allergan says exploring sale of obesity business
Reuters
Tuesday, October 30, 2012 - 11:42am
tags:
obesity, Allergan, lap band surgery, M&A
Dr. Reddy's beats forecasts; Q2 profit jumps on new drugs
Reuters
Tuesday, October 30, 2012 - 11:41am
tags:
earnings, Dr Reddy's
What Will The New AstraZeneca CEO Get Paid?
Pharmalot
Tuesday, October 30, 2012 - 11:40am
tags:
Pharma CEOs, Pascal Soriot, AstraZeneca, executive pay
Johnson & Johnson Postpones Medical Devices & Diagnostics Review
Yahoo
Tuesday, October 30, 2012 - 11:39am
tags:
JNJ, devices

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.